Anadrol 50 mg 50 Tablets Odin Pharma

Product Overview

Anadrol 50 mg 50 Tablets Odin Pharma presents oxymetholone, a synthetic anabolic-androgenic steroid identical to the 50 mg scored tablets in approved Anadrol-50 formulations. Each retail unit provides 50 tablets, offering experienced buyers the exact configuration found in pharmaceutical packaging for seamless catalog integration and controlled inventory management.​

The product belongs to Odin Pharma’s performance compound range, matching the CIII Schedule classification, molecular formula (C21H32O3), and tablet morphology of regulated oxymetholone products. This industry-standard presentation supports eCommerce platforms serving regulated markets where compliance demands precise strength declaration and batch traceability.​

Anadrol 50 mg targets knowledgeable adult consumers familiar with Schedule III anabolic steroids rather than general supplement categories, emphasizing commercial specifications without usage protocols or outcome representations.​

Brand & Manufacturer Information

Odin Pharma produces Schedule III anabolic steroids including oxymetholone 50 mg tablets alongside other performance compounds through specialist distribution channels. Products replicate pharmaceutical-grade specifications—scored white tablets, 50 mg potency, 50-count packaging—enabling recognition by professionals accustomed to Anadrol-50 standards.​

The brand maintains batch documentation matching FDA-regulated oxymetholone requirements, supporting traceability essential for resellers operating under controlled substance protocols. Odin Pharma positions within legitimate performance markets rather than recreational supplement sectors, with Anadrol appearing across verified specialist catalogs.​

Active Compound Information

Anadrol contains oxymetholone (17β-hydroxy-2-(hydroxymethylene)-17α-methyl-5α-androstan-3-one), a 17α-alkylated anabolic steroid derived from dihydrotestosterone with potent erythropoietic stimulation properties. Molecular weight 332.48; Schedule III controlled substance due to anabolic/androgenic profile and hepatotoxicity risk profile.​

Oxymetholone appears on WADA Prohibited List (S1 Anabolic Androgenic Steroids); non-medical possession/distribution regulated under DEA CIII, EU controlled substances directives, and equivalent international frameworks. This listing identifies pharmaceutical characteristics without describing indications, mechanisms, or protocols.​

Product Specifications

• Product name: Anadrol 50 mg 50 Tablets Odin Pharma

• Brand/manufacturer: Odin Pharma​

• Active compound: Oxymetholone (C21H32O3)​

• Strength: 50 mg per scored tablet​

• Quantity per pack: 50 tablets​

• Dosage form: Oral scored tablets

• Category: Anabolic-androgenic steroid, DEA Schedule III​

• Appearance: White, elliptical, scored tablets​

• Primary packaging: HDPE bottle with child-resistant cap​

• Label elements: “50 mg”, total count, lot number, expiry per CIII standards​

Quality Control & Testing Standards

Oxymetholone 50 mg tablets require USP identity testing, 90-110% potency assay, dissolution (Q=80% in 30 min), and uniformity per Schedule III manufacturing controls. Odin Pharma batch documentation supports DEA-compliant traceability matching Alaven/Unipath standards for Anadrol-50.​

50-tablet count, scored morphology, and CIII labeling replicate FDA-approved packaging, distinguishing legitimate production from unregulated powder conversions common in grey markets.​

Intended Use & Market Positioning

Anadrol 50 mg 50 Tablets serves informed adult buyers and CIII-authorized intermediaries familiar with Schedule III anabolic steroid handling requirements. Exact pharmaceutical match positions within advanced performance catalogs without entry-level appeal. No dosing, cycling, or outcomes represented.​

Packaging, Storage & Handling

Supplied in sealed HDPE bottles with desiccant per CIII requirements, protecting from light/moisture degradation (stable 24 months at 25°C/60% RH). Store locked, room temperature, inventory logs per DEA protocols; access restricted to 21+ adults or licensed personnel.​

Purchasing & Availability Information

Listed on CIII-compliant specialist platforms with encrypted checkout, age/ID verification, and unmarked outer packaging. “50 mg 50 Tablets” nomenclature prevents confusion with 25 mg research chems; supports DEA record-keeping for repeat institutional procurement.​

Legal & Regulatory Disclaimer

Oxymetholone constitutes DEA Schedule III controlled substance; non-medical manufacture, distribution, possession illegal under 21 USC §812, EU Directive 2001/83/EC. Buyer assumes complete liability for Form 222 compliance, state licensing, and jurisdictional verification; zero medical claims or protocols provided.​